Picture of BBS-Bioactive Bone Substitutes Oyj logo

BONEH — BBS-Bioactive Bone Substitutes Oyj News Story

0.000.00%
fi flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: BBS-Bioactive Bone Substitutes Says Clinical Result Of Artebone Is Positive Yielding An Outcome Similar To Patient's Own Bone Graft

Feb 19 (Reuters) - BBS-Bioactive Bone Substitutes Oyj
 BONEH.HE :
    * CLINICAL RESULT OF ARTEBONE IS POSITIVE YIELDING AN
OUTCOME
SIMILAR TO PATIENT'S OWN BONE GRAFT
    * MAIN RESULT SHOWS THAT FUSION RATE WITH ARTEBONE PASTE IS
COMPARABLE WITH FUSION RATE WITH AUTOGRAFT
    * NO SYNTHETIC SUBSTITUTE MATERIAL HAS SHOWN SIMILAR BONE
GROWTH
POTENTIAL WHILE KEEPING SAFETY AT HIGH LEVEL
    * RESULTS WERE COMPARED TO LITERATURE REFERENCES ON
AUTOGRAFT
    * EXPECTS TO RECEIVE CE MARKING OF ARTEBONE, TO BE ABLE TO
START
COMMERCIAL OPERATIONS IN EUROPEAN MARKETS WITHIN A YEAR
    * CO IS AIMING TO START BUILDING ITS MARKETING AND SALES
NETWORK
STARTING IN LATE SPRING

Source text for Eikon:  ID:nGNEbPC30Y 
Further company coverage:  BONEH.HE 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on BBS-Bioactive Bone Substitutes Oyj

See all news